Cytek Biosciences, Inc. CTKB United States — Total revenue, net
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s united states — total revenue, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s united states — total revenue, net?
- Cytek Biosciences, Inc. (CTKB) reported united states — total revenue, net of $24.4M in Q1 2026.
- How has Cytek Biosciences, Inc.'s united states — total revenue, net changed year-over-year?
- Cytek Biosciences, Inc.'s united states — total revenue, net increased by 31.6% year-over-year, from $18.54M to $24.4M.
- What is the long-term trend for Cytek Biosciences, Inc.'s united states — total revenue, net?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s united states — total revenue, net has grown at a 7.0% compound annual growth rate (CAGR), from $72.72M to $95.26M.
- What does united states — total revenue, net mean?
- This metric represents the total net revenue generated from product sales and services within the United States geographic region. It reflects the company's market penetration and demand for its specialized analytical instrumentation and associated consumables in this specific territory. Tracking this figure helps investors assess regional growth trends and the effectiveness of local commercial operations.